GSK will evaluate Consumer Healthcare options

5 July 2021 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK ) will “evaluate any alternative options for Consumer Healthcare that may arise”, according to the company’s board, which says it is close to appointing a chief executive officer designate for the business ahead of the proposed separation.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: